Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study
<i>Background and Objectives</i>: The human gut microbiome is essential for the health of the host and is affected by antibiotics and coronavirus disease 2019 (COVID-19). The gut microbiome is recognized as a contributing factor in the development of ulcerative colitis. Specific vitamins...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/2/284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850081326200258560 |
|---|---|
| author | Zane Straume Nikola Krūmiņa Ilze Elbere Maija Rozenberga Renārs Erts Dace Rudzīte Anna Proskurina Angelika Krumina |
| author_facet | Zane Straume Nikola Krūmiņa Ilze Elbere Maija Rozenberga Renārs Erts Dace Rudzīte Anna Proskurina Angelika Krumina |
| author_sort | Zane Straume |
| collection | DOAJ |
| description | <i>Background and Objectives</i>: The human gut microbiome is essential for the health of the host and is affected by antibiotics and coronavirus disease 2019 (COVID-19). The gut microbiome is recognized as a contributing factor in the development of ulcerative colitis. Specific vitamins and probiotics have been demonstrated to positively influence the microbiome by enhancing the prevalence of expected beneficial microorganisms. <i>Materials and Methods</i>: Forty-nine ulcerative colitis (UC) outpatients from Riga East Clinical University Hospital were enrolled in this cross-sectional study from June 2021 to December 2021. All patients were divided into groups based on history of COVID-19 (COVID-19 positive vs. COVID-19 negative) in the last six months. Information about antibiotic, probiotic, and vitamin intake were outlined, and faecal samples were collected. The MetaPhlAn v.2.6.0 tool was used for the taxonomic classification of the gut microbiome metagenome data. Statistical analysis was performed using R 4.2.1. <i>Results</i>: Of the 49 patients enrolled, 31 (63%) were male and 18 (37%) were female. Coronavirus disease 2019 was found in 14 (28.6%) patients in the last 6 months. <i>Verrucomicrobia</i> was statistically significantly lower in the COVID-19 positive group (M = 0.05; SD = 0.11) compared to the COVID-19 negative group (M = 0.5; SD = 1.22), <i>p</i> = 0.03. Antibiotic non-users had more <i>Firmicutes</i> in their microbiome than antibiotic users (<i>p</i> = 0.008). The most used vitamin supplement was vitamin D (N = 18), fifteen (42.9%) of the patients were COVID-19 negative and 3 (21.4%) were COVID-19 positive over the last six months (<i>p</i> > 0.05). Vitamin C users had more <i>Firmicutes</i> in their gut microbiome compared to non-users (Md = 72.8 [IQR: 66.6; 78.7] vs. Md = 60.1 [IQR: 42.4; 67.7]), <i>p</i> = 0.01. <i>Conclusions</i>: Antibiotic non-users had more <i>Firmicutes</i> than antibiotic users in their gut microbiome. Only vitamin C had statistically significant results; in users, more <i>Firmicutes</i> were observed. A mild course of COVID-19 may not influence ulcerative colitis patients’ gut microbiome. |
| format | Article |
| id | doaj-art-99659206792e40199a047f50a6f8da4a |
| institution | DOAJ |
| issn | 1010-660X 1648-9144 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj-art-99659206792e40199a047f50a6f8da4a2025-08-20T02:44:46ZengMDPI AGMedicina1010-660X1648-91442025-02-0161228410.3390/medicina61020284Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional StudyZane Straume0Nikola Krūmiņa1Ilze Elbere2Maija Rozenberga3Renārs Erts4Dace Rudzīte5Anna Proskurina6Angelika Krumina7Gastroenterology, Hepatology and Nutrition Clinic, Riga East Clinical University Hospital, LV-1038 Riga, LatviaDepartment of Internal Diseases, Riga Stradins University, LV-1007 Riga, LatviaLatvian Biomedical Research and Study Centre, LV-1067 Riga, LatviaLatvian Biomedical Research and Study Centre, LV-1067 Riga, LatviaThe Faculty of Medicine and Life Sciences, University of Latvia, LV-1004 Riga, LatviaGastroenterology, Hepatology and Nutrition Clinic, Riga East Clinical University Hospital, LV-1038 Riga, LatviaDepartment of Internal Diseases, Riga Stradins University, LV-1007 Riga, LatviaDepartment of Internal Diseases, Riga Stradins University, LV-1007 Riga, Latvia<i>Background and Objectives</i>: The human gut microbiome is essential for the health of the host and is affected by antibiotics and coronavirus disease 2019 (COVID-19). The gut microbiome is recognized as a contributing factor in the development of ulcerative colitis. Specific vitamins and probiotics have been demonstrated to positively influence the microbiome by enhancing the prevalence of expected beneficial microorganisms. <i>Materials and Methods</i>: Forty-nine ulcerative colitis (UC) outpatients from Riga East Clinical University Hospital were enrolled in this cross-sectional study from June 2021 to December 2021. All patients were divided into groups based on history of COVID-19 (COVID-19 positive vs. COVID-19 negative) in the last six months. Information about antibiotic, probiotic, and vitamin intake were outlined, and faecal samples were collected. The MetaPhlAn v.2.6.0 tool was used for the taxonomic classification of the gut microbiome metagenome data. Statistical analysis was performed using R 4.2.1. <i>Results</i>: Of the 49 patients enrolled, 31 (63%) were male and 18 (37%) were female. Coronavirus disease 2019 was found in 14 (28.6%) patients in the last 6 months. <i>Verrucomicrobia</i> was statistically significantly lower in the COVID-19 positive group (M = 0.05; SD = 0.11) compared to the COVID-19 negative group (M = 0.5; SD = 1.22), <i>p</i> = 0.03. Antibiotic non-users had more <i>Firmicutes</i> in their microbiome than antibiotic users (<i>p</i> = 0.008). The most used vitamin supplement was vitamin D (N = 18), fifteen (42.9%) of the patients were COVID-19 negative and 3 (21.4%) were COVID-19 positive over the last six months (<i>p</i> > 0.05). Vitamin C users had more <i>Firmicutes</i> in their gut microbiome compared to non-users (Md = 72.8 [IQR: 66.6; 78.7] vs. Md = 60.1 [IQR: 42.4; 67.7]), <i>p</i> = 0.01. <i>Conclusions</i>: Antibiotic non-users had more <i>Firmicutes</i> than antibiotic users in their gut microbiome. Only vitamin C had statistically significant results; in users, more <i>Firmicutes</i> were observed. A mild course of COVID-19 may not influence ulcerative colitis patients’ gut microbiome.https://www.mdpi.com/1648-9144/61/2/284ulcerative colitismicrobiomeprobioticsvitaminsantibioticsCOVID-19 |
| spellingShingle | Zane Straume Nikola Krūmiņa Ilze Elbere Maija Rozenberga Renārs Erts Dace Rudzīte Anna Proskurina Angelika Krumina Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study Medicina ulcerative colitis microbiome probiotics vitamins antibiotics COVID-19 |
| title | Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study |
| title_full | Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study |
| title_fullStr | Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study |
| title_full_unstemmed | Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study |
| title_short | Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study |
| title_sort | impact of vitamins antibiotics probiotics and history of covid 19 on the gut microbiome in ulcerative colitis patients a cross sectional study |
| topic | ulcerative colitis microbiome probiotics vitamins antibiotics COVID-19 |
| url | https://www.mdpi.com/1648-9144/61/2/284 |
| work_keys_str_mv | AT zanestraume impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT nikolakrumina impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT ilzeelbere impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT maijarozenberga impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT renarserts impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT dacerudzite impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT annaproskurina impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy AT angelikakrumina impactofvitaminsantibioticsprobioticsandhistoryofcovid19onthegutmicrobiomeinulcerativecolitispatientsacrosssectionalstudy |